Supplement Figure 2
Resource utilisation for (A) year 1 and (B) year 2 completers according to number of ranibizumab injections received during year 1 (<5, 5-7, >7 injections) and over the 2-year period (<10, 10-14, >14 injections).
FA, fluorescein angiography; ICGA, indocyanine green angiography; OCT, optical coherence tomography. *p<0.05; †p<0.001 between groups (p-value was derived from analysis of variance for continuous variables and chi-squared test for categorical variables). 
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